Also on Friday, the Food and Drug Administration informally requested that Sarepta voluntarily pause shipments of another gene therapy, Elevidys, which is approved to treat a different type of ...

As the date for the completion of the All Seasons Arena renovations gets closer, the Blue Earth County Board will consider a ...

Families of missing loved ones face a unique and agonizing grief called ambiguous loss. Experts explain this as the pain of ...

Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.

A local nonprofit is navigating uncertainty with several programs on the chopping block. Disability Rights Ohio serves as an advocate for people with disabilities.

Culver’s, which operates 1,000 locations across 26 states, is opening nearly two dozen new locations before the end of the year. Unsurprisingly, Wisconsin, where Culver’s was founded, has the greatest ...

Mel Cozzi and George Howe, Board of Commissioners for the City of Oregon, join WGN Radio’s Dave Plier to highlight the City of Oregon and all that it has to offer for visitors. Mel and ...

Drugmaker Sarepta Therapeutics said late Friday it won't comply with a request from the Food and Drug Administration to halt ...

Sarepta Therapeutics announced it is laying off nearly 500 employees this week, including 80 at its Easton location.

Sarepta rebuffed a call from the Food and Drug Administration to halt all shipments of its gene therapy for Duchenne muscular ...

American Express said Friday that travel spending in the quarter was weaker than transactions for goods and services.

Shares of Sarepta Therapeutics plunged more than 30% on Friday as the future of its approved gene therapy appeared at risk.